Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.0600 (-4.32%) ($13.0600 - $13.0600) on Fri. Feb. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.94% (three month average) | RSI | 34 | Latest Price | $13.0600(-4.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(51%) IBB(48%) ARKG(47%) ARKK(47%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.97% in a week (0% probabilities). VIXM(-43%) VXX(-32%) UNG(-18%) USO(-15%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.97% (StdDev 3.94%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.3(-51.76%) | Resistance Level | $14.75 | 5 Day Moving Average | $14.14(-7.64%) | 10 Day Moving Average | $14.59(-10.49%) | 20 Day Moving Average | $14.75(-11.46%) | To recent high | -28.7% | To recent low | 0% | Market Cap | $970m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |